# Antibiotic and Antibiotic-Steroid Combination Drops and Ointments

This is a subcategory of Opthalmic Agents.

## Formulary

### Preferred

| Preferred                                    | Generic Name | Quantity | Time (Days) |
| :------------------------------------------- | :----------- | :------: | :---------: |
| Bacitracin-Polymyxin                         |              |          |             |
| Ciloxan                                      |              |          |             |
| Ciprofloxacin                                |              |          |             |
| Erythromycin                                 |              |          |             |
| Gentamicin                                   |              |          |             |
| Moxifloxacin                                 |              |          |             |
| Neomycin/Polymyxin/Bacitracin                |              |          |             |
| Neomycin/Polymyxin/Bacitracin/Hydrocortisone |              |          |             |
| Neomycin/Polymyxin/Dexamethasone             |              |          |             |
| Neomycin/Polymyxin/Gramicidin                |              |          |             |
| Ofloxacin                                    |              |          |             |
| Polymyxin/Trimethoprim                       |              |          |             |
| Sulfacetamide Sodium Ophth Sol 10%           |              |          |             |
| Sulfacetamide/Prednisolone                   |              |          |             |
| Tobradex BvG                                 |              |          |             |
| Tobramycin                                   |              |          |             |

### Non-Preferred

| Non-Preferred                     | Generic Name | Quantity | Time (Days) |
| :-------------------------------- | :----------- | :------: | :---------: |
| Azasite                           |              |          |             |
| Bacitracin                        |              |          |             |
| Besivance                         |              |          |             |
| Blephamide                        |              |          |             |
| Gatifloxacin                      |              |          |             |
| Levofloxacin                      |              |          |             |
| Moxifloxacin (Generic of Moxeza)  |              |          |             |
| Neomycin/Polymyxin/Hydrocortisone |              |          |             |
| Pred-G                            |              |          |             |
| Tobradex ST BvG                   |              |          |             |
| Tobramycin/Dexamethasone 0.3/0.1% |              |          |             |
| Zylet                             |              |          |             |

## Length of Authorizations

For the date of service only; no refills for acute infection. Refills for up to 14 days may be authorized for quinolones only for patients undergoing surgery.

## Prior Authorization Criteria

1.  Is there any reason the patient cannot be changed to a medication not requiring prior approval? Acceptable reasons include:
    -   Allergy to medications not requiring prior approval
    -   Contraindication to or drug interaction with medications not requiring prior approval
    -   History of unacceptable/toxic side effects to medications not requiring prior approval
2.  If the infection is caused by an organism resistant to medications not requiring prior approval, then may approve the requested medication.
    -   Note diagnosis and any culture and sensitivity reports
3.  For a non-preferred agent, there must have been inadequate clinical response to preferred alternatives, including a trial of no less than **3 days each** of at least **two** preferred products

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_Criteria_APPROVED.pdf#page=82)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20221001_UPDL_APPROVED_.pdf#page=28)
